Cancer is a major disease and a heavy burden to public health. With the rapid development
of high-throughput (HTP) technologies, increasing multi-omics data have been produced to …

Cancer is one of the major causes threatening human health and life. With the rapid
development of cancer genomics and bioinformatics analysis methods, a number of tumor …

Cancer remains a severe public health burden globally. The identification of molecular
biomarkers play significant roles in diagnosis, treatment and prognosis of human cancers …

During the past century, our understanding of cancer diagnosis and treatment has been
based on a monogenic approach, and as a consequence our knowledge of the clinical …

The rapid advancement of high-throughput technologies, particularly next-generation
sequencing (NGS), has revolutionized cancer research by enabling the investigation of …

Prognostic biomarkers are of great significance to predict the outcome of patients with
cancer, to guide the clinical treatments, to elucidate tumorigenesis mechanisms, and offer …

Cancer has been constantly evolving and so is the research pertaining to cancer diagnosis
and therapeutic regimens. Early detection and specific therapeutics are the key features of …

Due to the explosion of cancer genome data and the urgent needs for cancer treatment, it is
becoming increasingly important and necessary to easily and timely analyze and annotate …

Aim: Existing targeted therapies for hepatocellular carcinoma (HCC) are resistant and have
limitations. It is crucial to find new HCC-related target genes. Methods: RNA-sequencing …

Cao MD, Song YC, Yang ZM, Wang DW, Lin YM, Lu HD. Onco Targets Ther. 2020; 13: 8095-
8107. We, the Editors and Publisher of OncoTargets and Therapy, have retracted the …